Prospective, Single-centre, Open-Label, Randomised, Pilot Study Assessing the changes in expression of JAK-STAT and Speed & Depth of Remission Induced by Tocilizumab & Methotrexate Combination and Tocilizumab Monotherapy in Patients with Early Rheumatoid Arthritis (TREMERA).
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2019
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms TREMERA
- 08 Jun 2019 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism